explore -WSS

explore

author：fashion 2025-09-28 08:33:57 Page View：4942

UCB website -- health policy coverage from STAT — Adobe

WASHINGTON — UCB left BIO at the end of 2023, the second major member company to exit after Pfizer pulled out as well.

UCB, headquartered in Belgium, decided not to renew its BIO membership after a routine evaluation of its engagement in trade associations, said company spokesperson Erica Puntel.

Newsletters

Sign up for D.C. Diagnosis

Washington never stops. Cut through the noise with our essential updates on health care politics and policy

Please enter a valid email address. Privacy Policy

Pfizer, whose departure STAT reported first, was listed on BIO’s website as a sponsor at one of the group’s highest levels. Pfizer bought Global Blood Therapeutics, which current BIO Board Chair Ted Love led to the approval of a drug to treat sickle cell disease, in 2022.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The EU Joint Clinical Assessment needs to live up to its promise
Next article： Alkermes shareholders re

explore

Moonlake's readout produced a cash windfall. Risks remain

MollyFerguson/STATFortwodaysstartingonSunday,MoonlakeImmunotherapeuticshappilycrunchednumbersandshar

Researchers explore possible ties between long Covid, menopause

AdobeWhenshestoppedgettingherperiodinMarch2022,DarynSchwartzwasn’tespeciallyconcerned.At42,shehadrec

How to save PrEP access — and even expand it

UndertheAffordableCareAct,healthinsurersarerequiredtocoverallcostsassociatedwithpreventivecare—inclu

North Korean leader's powerful sister says warplanes repelled US spy plane

FILE-KimYoJong,sisterofNorthKorea'sleaderKimJongUn,attendsawreath-layingceremonyatHoChiMinhMausoleum